Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.170
0.00 (0.00%)
At close: Apr 8, 2026, 4:00 PM EDT
1.190
+0.020 (1.71%)
After-hours: Apr 8, 2026, 4:55 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $54.55 million as of April 8, 2026. Its market cap has decreased by -38.41% in one year.
Market Cap
54.55M
Enterprise Value
48.16M
1-Year Change
-38.41%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $54.55M, a decrease of -24.00%. That is a compound annual growth rate of -3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 54.55M | -38.68% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 59.80M |
| OnKure Therapeutics | 59.48M |
| TScan Therapeutics | 59.18M |
| Estrella Immunopharma | 58.02M |
| Instil Bio | 57.38M |
| MiNK Therapeutics | 56.81M |
| MindWalk Holdings | 56.12M |
| Kezar Life Sciences | 54.55M |